Published in Am J Ophthalmol on April 01, 2012
[Refractive changes after Descemet membrane endothelial keratoplasty]. Ophthalmologe (2014) 0.84
DMEK in phakic eyes: targeted therapy or highway to cataract surgery? Graefes Arch Clin Exp Ophthalmol (2015) 0.81
[Pediatric corneal surgery and corneal transplantation]. Ophthalmologe (2015) 0.80
Descemet membrane endothelial keratoplasty (DMEK) in phakic eyes with shallow anterior chamber. Graefes Arch Clin Exp Ophthalmol (2014) 0.75
Corneal endothelial cell analysis using two non-contact specular microscopes in healthy subjects. Int Ophthalmol (2015) 0.75
[Treatment of corneal endothelial disorders by DMEK and UT-DSAEK : Indications, complications, results and follow-up]. Ophthalmologe (2016) 0.75
[Triple Descemet membrane endothelial keratoplasty : Indications, variations and results]. Ophthalmologe (2016) 0.75
Changes in Anterior, Posterior, and Total Corneal Astigmatism after Descemet Membrane Endothelial Keratoplasty. J Ophthalmol (2017) 0.75
Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest (2005) 3.77
Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunity. Nat Med (2004) 2.64
Identification and characterization of limbal stem cells. Exp Eye Res (2005) 2.38
Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival. Invest Ophthalmol Vis Sci (2004) 2.27
Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis. Invest Ophthalmol Vis Sci (2007) 2.05
Epithelial-Mesenchymal Transition (EMT)-Related Cytokines in the Aqueous Humor of Phakic and Pseudophakic Fuchs' Dystrophy Eyes. Invest Ophthalmol Vis Sci (2015) 2.04
Cutting edge: lymphatic vessels, not blood vessels, primarily mediate immune rejections after transplantation. J Immunol (2009) 1.97
Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor. Invest Ophthalmol Vis Sci (2003) 1.93
Optimizing descemet membrane endothelial keratoplasty using intraoperative optical coherence tomography. JAMA Ophthalmol (2013) 1.82
Heterozygous NTF4 mutations impairing neurotrophin-4 signaling in patients with primary open-angle glaucoma. Am J Hum Genet (2009) 1.71
Association of LOXL1 common sequence variants in German and Italian patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Invest Ophthalmol Vis Sci (2008) 1.71
Descemet membrane endothelial keratoplasty versus descemet stripping automated endothelial keratoplasty. Am J Ophthalmol (2012) 1.68
GS-101 antisense oligonucleotide eye drops inhibit corneal neovascularization: interim results of a randomized phase II trial. Ophthalmology (2009) 1.67
Pressure-induced interlamellar stromal keratitis after laser in situ keratomileusis. Cornea (2011) 1.66
Time course of angiogenesis and lymphangiogenesis after brief corneal inflammation. Cornea (2006) 1.66
Retinal nerve fiber layer thickness in normals measured by spectral domain OCT. J Glaucoma (2010) 1.55
Comparison of scanning laser polarimetry and optical coherence tomography in quantitative retinal nerve fiber assessment. J Glaucoma (2010) 1.53
Histologic analysis of descemet stripping in posterior lamellar keratoplasty. Arch Ophthalmol (2008) 1.52
Reproducibility of graft preparations in Descemet's membrane endothelial keratoplasty. Ophthalmology (2013) 1.51
Tumor-associated lymphangiogenesis in the development of conjunctival squamous cell carcinoma. Ophthalmology (2010) 1.46
Corneal limbal microenvironment can induce transdifferentiation of hair follicle stem cells into corneal epithelial-like cells. Stem Cells (2009) 1.46
Correlation between local glaucomatous visual field defects and loss of nerve fiber layer thickness measured with polarimetry and spectral domain OCT. Invest Ophthalmol Vis Sci (2009) 1.41
Surgery-related factors influencing corneal neovascularization after low-risk keratoplasty. Am J Ophthalmol (2006) 1.41
A stepwise approach to donor preparation and insertion increases safety and outcome of Descemet membrane endothelial keratoplasty. Cornea (2011) 1.40
Tumors of the lacrimal drainage system. Orbit (2010) 1.40
Genotype-correlated expression of lysyl oxidase-like 1 in ocular tissues of patients with pseudoexfoliation syndrome/glaucoma and normal patients. Am J Pathol (2008) 1.38
The Pathogenesis of floppy eyelid syndrome: involvement of matrix metalloproteinases in elastic fiber degradation. Ophthalmology (2005) 1.36
Risk factors for corneal allograft rejection: intermediate results of a prospective normal-risk keratoplasty study. Graefes Arch Clin Exp Ophthalmol (2002) 1.33
Differential gene expression in pseudoexfoliation syndrome. Invest Ophthalmol Vis Sci (2005) 1.33
Split cornea transplantation for 2 recipients: a new strategy to reduce corneal tissue cost and shortage. Ophthalmology (2010) 1.29
Inhibition of inflammatory lymphangiogenesis by integrin alpha5 blockade. Am J Pathol (2007) 1.29
Promotion of graft survival by vascular endothelial growth factor a neutralization after high-risk corneal transplantation. Arch Ophthalmol (2008) 1.27
Descemet membrane endothelial keratoplasty: the taming of the shrew. JAMA Ophthalmol (2013) 1.24
Descemet stripping endothelial keratoplasty--rapid recovery of visual acuity. Dtsch Arztebl Int (2013) 1.24
Novel anti(lymph)angiogenic treatment strategies for corneal and ocular surface diseases. Prog Retin Eye Res (2013) 1.22
From hair to cornea: toward the therapeutic use of hair follicle-derived stem cells in the treatment of limbal stem cell deficiency. Stem Cells (2011) 1.22
Novel expression and characterization of lymphatic vessel endothelial hyaluronate receptor 1 (LYVE-1) by conjunctival cells. Invest Ophthalmol Vis Sci (2005) 1.22
Bacterial keratitis early after corneal crosslinking with riboflavin and ultraviolet-A. J Cataract Refract Surg (2009) 1.21
Corneal neovascularization as a risk factor for graft failure and rejection after keratoplasty: an evidence-based meta-analysis. Ophthalmology (2010) 1.21
Blockade of VEGFR3-signalling specifically inhibits lymphangiogenesis in inflammatory corneal neovascularisation. Graefes Arch Clin Exp Ophthalmol (2007) 1.20
Clusterin deficiency in eyes with pseudoexfoliation syndrome may be implicated in the aggregation and deposition of pseudoexfoliative material. Invest Ophthalmol Vis Sci (2006) 1.18
Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin) eye drops against corneal neovascularization. Graefes Arch Clin Exp Ophthalmol (2009) 1.18
Long-term topical steroid treatment improves graft survival following normal-risk penetrating keratoplasty. Am J Ophthalmol (2007) 1.16
Bevacizumab (Avastin) eye drops inhibit corneal neovascularization. Graefes Arch Clin Exp Ophthalmol (2007) 1.15
Proinflammatory cytokines are involved in the initiation of the abnormal matrix process in pseudoexfoliation syndrome/glaucoma. Am J Pathol (2010) 1.15
Genome-wide association study with DNA pooling identifies variants at CNTNAP2 associated with pseudoexfoliation syndrome. Eur J Hum Genet (2010) 1.14
Corneal higher-order aberrations after Descemet's membrane endothelial keratoplasty. Ophthalmology (2011) 1.14
Ciliary body lymphangiogenesis. Ophthalmology (2013) 1.11
Diagnosis and treatment of ocular chronic graft-versus-host disease: report from the German-Austrian-Swiss Consensus Conference on Clinical Practice in chronic GVHD. Cornea (2012) 1.10
Preservation of the limbal stem cell phenotype by appropriate culture techniques. Invest Ophthalmol Vis Sci (2009) 1.09
Spontaneous corneal hem- and lymphangiogenesis in mice with destrin-mutation depend on VEGFR3 signaling. Am J Pathol (2005) 1.09
Optimising deep anterior lamellar keratoplasty (DALK) using intraoperative online optical coherence tomography (iOCT). Br J Ophthalmol (2014) 1.09
Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) on monocytic bone marrow-derived cells in the conjunctiva. Exp Eye Res (2004) 1.08
Regulation of lysyl oxidase-like 1 (LOXL1) and elastin-related genes by pathogenic factors associated with pseudoexfoliation syndrome. Invest Ophthalmol Vis Sci (2011) 1.07
Predictive factors of the optic nerve head for development or progression of glaucomatous visual field loss. Invest Ophthalmol Vis Sci (2004) 1.07
Pentacam-based big bubble deep anterior lamellar keratoplasty in patients with keratoconus. Cornea (2012) 1.07
Split cornea transplantation for 2 recipients - review of the first 100 consecutive patients. Am J Ophthalmol (2011) 1.07
Measuring contrast sensitivity in normal subjects with OPTEC 6500: influence of age and glare. Graefes Arch Clin Exp Ophthalmol (2007) 1.05
Pupillographic measurements with pattern stimulation: the pupil's response in normal subjects and first measurements in glaucoma patients. Invest Ophthalmol Vis Sci (2006) 1.05
Longitudinal analysis of progression in glaucoma using spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci (2013) 1.05
Intraocular lymphangiogenesis in malignant melanomas of the ciliary body with extraocular extension. Invest Ophthalmol Vis Sci (2009) 1.04
LOXL1 deficiency in the lamina cribrosa as candidate susceptibility factor for a pseudoexfoliation-specific risk of glaucoma. Ophthalmology (2012) 1.02
Safety profile of topical VEGF neutralization at the cornea. Invest Ophthalmol Vis Sci (2009) 1.02
Combination of transepithelial phototherapeutic keratectomy and autologous serum eyedrops for treatment of recurrent corneal erosions. J Cataract Refract Surg (2005) 1.02
Persisting corneal erosion under cetuximab (Erbitux) treatment (epidermal growth factor receptor antibody). Cornea (2008) 1.02
Homocysteine in tear fluid of patients with pseudoexfoliation glaucoma. J Glaucoma (2007) 1.02
High expression of chemokines Gro-alpha (CXCL-1), IL-8 (CXCL-8), and MCP-1 (CCL-2) in inflamed human corneas in vivo. Arch Ophthalmol (2003) 1.02
The prostaglandin transporter OATP2A1 is expressed in human ocular tissues and transports the antiglaucoma prostanoid latanoprost. Invest Ophthalmol Vis Sci (2009) 1.01
Split cornea transplantation: relationship between storage time of split donor tissue and outcome. Ophthalmology (2013) 1.01
Exploring functional candidate genes for genetic association in german patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Invest Ophthalmol Vis Sci (2009) 1.00
Suppression of inflammatory corneal lymphangiogenesis by application of topical corticosteroids. Arch Ophthalmol (2011) 1.00
Corneal (lymph)angiogenesis--from bedside to bench and back: a tribute to Judah Folkman. Lymphat Res Biol (2008) 1.00
The normal human choroid is endowed with a significant number of lymphatic vessel endothelial hyaluronate receptor 1 (LYVE-1)-positive macrophages. Invest Ophthalmol Vis Sci (2008) 0.98